Atlas Trials

Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies

Clinical trial NCT00714259 · TERMINATED

Trial details

NCT number
NCT00714259
Sponsor
University of Alabama at Birmingham
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Multiple MyelomaCLL / SLLNon Hodgkin's LymphomaWaldenstromsMantle Cell Lymphoma
Start date
2008-07-01
Primary completion
2013-02-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.